Linola-Fett (Unsaturated Fatty Acids (C18 : 2))

The C18:2 fatty acid, known as linoleic acid, is an essential component of the epidermal lipid matrix. When applied to the skin, it integrates into the stratum corneum, replenishing ceramides and free fatty acids, which strengthens barrier integrity, reduces transepidermal water loss, and modulates local inflammatory pathways.

The specific amount of Linola-Fett to apply is determined by the prescribing healthcare professional. Typically, a thin layer is spread over the affected area once or twice daily, but the exact regimen should follow the prescriber’s instructions based on the individual’s skin condition and response.

Safety data for Linola-Fett in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss use with their healthcare provider to weigh potential benefits against any unknown risks.

To order Linola-Fett, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details (including any cold‑chain requirements), and import documentation.

Unlike simple emollients, Linola-Fett supplies essential linoleic acid, an omega‑6 fatty acid that the skin cannot synthesize. This distinguishes it from basic moisturizers by actively contributing to lipid barrier reconstruction, whereas many over‑the‑counter creams rely mainly on occlusive agents without providing essential fatty acids.

Store Linola-Fett at room temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability and prevent contamination.

Linola-Fett is applied topically to clean, dry skin. A thin, even layer should be spread over the target area using clean hands or a sterile applicator, as directed by a healthcare professional. The product is not intended for oral ingestion.

The most serious risks include severe allergic reactions such as anaphylaxis, extensive blistering, or widespread urticaria. If any signs of systemic hypersensitivity—such as swelling of the face, throat, difficulty breathing, or a sudden rash—appear, discontinue use immediately and seek medical attention.

Individuals with a known hypersensitivity to linoleic acid, any component of the formulation, or those with severely compromised or infected skin should avoid using Linola-Fett. Additionally, patients who have experienced severe cutaneous reactions to similar fatty‑acid products should consult a clinician before use.